Fatty acid oxidation organizes mitochondrial supercomplexes to sustain astrocytic ROS and cognition.
Brenda Morant-FerrandoDaniel Jimenez-BlascoPaula Alonso-BatanJesús AgullaRebeca LapresaDario Garcia-RodriguezSara Yunta-SanchezIrene Lopez-FabuelEmilio FernandezPeter CarmelietÁngeles AlmeidaMarina García MaciaJuan Pedro BolañosPublished in: Nature metabolism (2023)
Having direct access to brain vasculature, astrocytes can take up available blood nutrients and metabolize them to fulfil their own energy needs and deliver metabolic intermediates to local synapses 1,2 . These glial cells should be, therefore, metabolically adaptable to swap different substrates. However, in vitro and in vivo studies consistently show that astrocytes are primarily glycolytic 3-7 , suggesting glucose is their main metabolic precursor. Notably, transcriptomic data 8,9 and in vitro 10 studies reveal that mouse astrocytes are capable of mitochondrially oxidizing fatty acids and that they can detoxify excess neuronal-derived fatty acids in disease models 11,12 . Still, the factual metabolic advantage of fatty acid use by astrocytes and its physiological impact on higher-order cerebral functions remain unknown. Here, we show that knockout of carnitine-palmitoyl transferase-1A (CPT1A)-a key enzyme of mitochondrial fatty acid oxidation-in adult mouse astrocytes causes cognitive impairment. Mechanistically, decreased fatty acid oxidation rewired astrocytic pyruvate metabolism to facilitate electron flux through a super-assembled mitochondrial respiratory chain, resulting in attenuation of reactive oxygen species formation. Thus, astrocytes naturally metabolize fatty acids to preserve the mitochondrial respiratory chain in an energetically inefficient disassembled conformation that secures signalling reactive oxygen species and sustains cognitive performance.
Keyphrases
- fatty acid
- reactive oxygen species
- oxidative stress
- cognitive impairment
- hydrogen peroxide
- cerebral ischemia
- white matter
- dna damage
- cell death
- type diabetes
- risk assessment
- nitric oxide
- blood pressure
- mild cognitive impairment
- subarachnoid hemorrhage
- cell cycle arrest
- gene expression
- electronic health record
- genome wide
- rna seq
- molecular dynamics simulations
- multiple sclerosis
- case control
- spinal cord injury
- blood glucose